Equity futures are sending a split message this Tuesday morning. S&P 500 futures are flat at 7,573 (-0.01%), Nasdaq futures are down 0.47% and Dow futures are up 0.34%. Fed Governor Christopher Waller's lean toward a December rate hike is forcing a repositioning out of long-duration growth and into rate beneficiaries and defensives. Financials are the clear pre-market leader at +0.90%, with Morgan Stanley (MS +1.50%), JPMorgan (JPM +1.18%) and Mastercard (MA +1.10%) bid. Rate-sensitive semiconductors are on the back foot: AMD is down 1.17%, Broadcom (AVGO) 0.93% and NVIDIA (NVDA) 0.70%.
The main event is the 8:30 ET October CPI report. The consensus setup is benign on a monthly basis, with headline at +0.3% versus +0.6% prior and core at +0.2% versus +0.3%. Year-over-year comparisons, however, are expected to move the wrong way: headline to 3.9% from 3.7% and core to 2.8% from 2.6%. With prediction markets assigning a 98% probability to no Fed cuts in 2026 and Waller now openly entertaining a hike, the bar for a relief rally is a core print at or below 0.2%. Anything firmer likely cements December hike pricing. Later today, a 10-year note auction (prior high yield 5.300%) will test duration demand. Yesterday's 3-year auction cleared at 4.627%, well below the prior 4.932%, a modestly encouraging sign for Treasury demand.
Positioning argues for caution around the number. SPY implied volatility sits at the 100th percentile (IV Rank 96) with puts carrying a premium, and the nearest-expiry implied move is ±1.1%. More importantly, dealers have been short gamma for 19 consecutive sessions, at roughly -$6.55 billion per 1% move. Spot sits below the 759 zero-gamma level, and both the call and put walls are pinned at SPY 750. That configuration tends to amplify, not dampen, directional moves, so a CPI surprise in either direction could extend intraday. Conversely, an in-line print could trigger a meaningful volatility crush given how richly options are priced.
Below the surface, the rotation is decidedly defensive. Health Care (+0.61%) is firm, led by Johnson & Johnson (JNJ +1.13%) and AbbVie (ABBV +0.89%). Eli Lilly (LLY +0.79%) is unfazed by the FDA's order to add vision-loss warnings to certain GLP-1 products. Staples (+0.49%) are bid via Walmart (WMT +0.91%) and Coca-Cola (KO +0.70%). Energy (-0.79%) is the weakest group as crude drops 2.25% to $84.90, with refiners Marathon Petroleum (MPC -1.74%) and Valero (VLO -1.33%) underperforming. Caterpillar (CAT -3.87%) is an outsized stock-specific drag on Industrials. Gold's 0.74% decline to $4,084 is weighing on Newmont (NEM -2.19%). In speculative pockets, space names remain heavy, with AST SpaceMobile and Rocket Lab under pressure despite backlog strength. IBD also notes that only three of the S&P 500's 20 biggest losers from November 5 have recovered, a sign that dip-buying conviction remains thin.
Looking ahead, the inflation gauntlet continues. Thursday brings initial jobless claims (consensus 195K) and the 30-year bond auction, followed by PPI on Friday (headline +0.4% m/m, 6.6% y/y; core 5.0% y/y). Several Fed officials are also scheduled to speak this week, including Logan, Bowman and Schmid today. The international tape is supportive, with the Nikkei up 2.87% to a record-area 60,460 and the DAX up 1.22%. Domestically, the path of least resistance hinges on whether CPI confirms or challenges the Fed's hawkish drift. Until then, expect leadership to favor banks and defensives over semis, with elevated odds of an outsized move in either direction given the negative-gamma backdrop.
Get the free daily briefing by email — plus a preview of our quantitative stock rankings, macro context, and AI research debate.
Sanctuary Research provides quantitative investment research and educational content — not personalized investment advice. Markets involve risk; do your own due diligence.